Overview


According to FutureWise analysis, the market for Stem Cell Manufacturing in 2023 is US$ 12.70 billion, and is expected to reach US$ 30.38 billion by 2031 at a CAGR of 11.50%.

Stem cell manufacturing is the process of creating or producing stem cells for use in medical research, therapeutic treatments, and other applications. Stem cells are cells that may grow into several types of cells in the body, making them valuable for medical research and treatment. The process of stem cell manufacturing typically involves several steps, including the collection of source materials, isolation and purification of stem cells, expansion of the stem cells, characterization and quality control testing. The source materials for stem cell manufacturing can rely on the type of stem cells being produced but commonly include bone marrow, adipose tissue, and umbilical cord blood.

Once the source material is collected, the stem cells are isolated and purified through a variety of methods, such as fluorescence-activated cell sorting (FACS), magnetic-activated cell sorting (MACS), and density gradient centrifugation. These methods allow the stem cells to be separated from other types of cells in the source material. After the extraction and purification of the stem cells, they are typically expanded in culture to generate larger numbers of cells for research or therapeutic applications. This can be accomplished by using specialized growth factors and culture media, which provide the necessary nutrients and signals to support stem cell growth and proliferation. Throughout the stem cell manufacturing process, characterization and quality control testing are performed to ensure the stem cells meet specific standards for purity, identity, potency, and safety. This may include testing for genetic markers, cell surface antigens, and functional assays to assess the stem cell's ability to differentiate into different cell types.

FutureWise Market Research has published a report that provides an insightful analysis of Stem Cell Manufacturing Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts projects that Stem Cell Manufacturing Market will experience a significant growth.

According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.

  • Thermo Fisher Scientific 
  • Merck Millipore 
  • Lonza Group AG 
  • Danaher Corporation 
  • Sartorius AG 
  • Bio-Rad Laboratories 
  • Becton, Dickinson and Company 
  • Stemcell Technologies 
  • Fujifilm Holdings Corporation 
  • Miltenyi Biotec 
  • Terumo BCT Inc. 
  • Corning Inc. 
  • Bio-Techne Corporation 
  • Takara Bio Group 
  • Eppendorf AG 

Recent developments by key players in Stem Cell Manufacturing Market:

  • In January 2022, Cellino Biotech, a firm manufacturing stem cells, secured a US $80 million Series A fundraising round from Leaps by Bayer, 8VC, Humboldt Fund, and new investors Felicis Ventures and Khosla Ventures. This funding might help Cellino Biotech address many obstacles hindering the biotech sector. The first autonomous human cell foundry will be constructed by Cellino in 2025 as part of its objective to increase access to stem cell-based medicines.

The field of stem cell manufacturing has seen tremendous growth in recent years, driven by advances in stem cell research and the invention of new techniques for producing stem cells in large quantities. One of the main drivers of the stem cell manufacturing market is the increasing demand for stem cell therapies. Stem cell therapies have the ability to treat a range of diseases and ailments, including cancer, neurological disorders, and cardiovascular disease. As more research is conducted and more clinical trials are carried out, the potential of stem cell therapies becomes increasingly clear, leading to greater demand for stem cells and stem cell-based products. In addition, the increasing focus on personalized medicine and precision medicine is also driving the growth of the stem cell manufacturing market. Stem cells can be used to develop personalized therapies that are tailored to an individual's unique genetic makeup, making them particularly attractive for the treatment of genetic disorders and other conditions that are difficult to treat with traditional therapies. Another factor driving the growth of the stem cell manufacturing market is the increasing investment in stem cell research and development. Governments, academic institutions, and private companies are investing heavily in stem cell research, leading to the development of novel technologies and techniques for producing stem cells in large quantities.

However, there are also many difficulties faced by the stem cell manufacturing market. One of the main barriers is the complex regulatory environment surrounding stem cell research and development. Regulations vary by country and region, making it complex for businesses to navigate the regulatory landscape and obtain the necessary approvals to develop and commercialize stem cell-based products.

By Product

  • Consumables
    • Culture Media
    • Other Consumables
  • Instruments
    • Bioreactors and Incubators
    • Cell Sorters
    • Other Instruments
  • Stem Cell Lines
    • Hematopoietic stem cells (HSC)
    • Mesenchymal stem cells (MSC)
    • Induced Pluripotent Stem cells (iPSC)
    • Embryonic stem cells (ESC)
    • Neural Stem cells (NSC)
    • Multipotent adult progenitor stem cells

By Application  

  • Research Applications
    • Life science research
    • Drug discovery and development
  • Clinical Application
    • Allogenic stem cell therapy
    • Autologous stem cell therapy
  • Cell & Tissue Banking Applications

By End User

  • Pharmaceutical & Biotechnology Companies
  • Academic institutes, Research laboratories & contract research organizations
  • Hospitals & surgical centers
  • Cell & tissue banks
  • Other End Users

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered the highest share in the market in 2022. The dominant player in the stem cell manufacturing market is North America. The U.S., in particular, has been at the forefront of stem cell research and development for many years, with a significant number of stem cell companies and academic research institutions located in the country. In addition, the U.S. govt. has invested heavily in stem cell research, providing funding for both clinical trials and basic research. Canada also holds a notable position in the stem cell manufacturing market as a significant player, with several academic research institutions and biotechnology companies focused on stem cell research and development.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Stem Cell Manufacturing Market By Product, By Application, By End User and By Region.
  • To cater comprehensive insights on factors such as drivers, restraints, trends, opportunity, and additionally segmental and regional factors impacting market growth.
  • To evaluate current market trends and forecast micro-markets and the overall market projections which are represented in the format of data-sets and ppt.
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To provide information on competitors which includes landscape mapping, technological advancements, R&D spending, news concerning strategic alliances, and new product launches.

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

 

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Stem Cell Manufacturing Market Variables, Trends and Scope

    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Stem Cell Manufacturing Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Stem Cell Manufacturing Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Stem Cell Manufacturing Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Stem Cell Manufacturing Market, By Product Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Consumables
         1.1. Culture Media
         1.2. Other Consumables
        2. Instruments
         2.1. Bioreactors and Incubators
         2.2. Cell Sorters
         2.3. Other Instruments
        3. Stem Cell Lines
         3.1. Hematopoietic stem cells (HSC)
         3.2. Mesenchymal stem cells (MSC)
         3.3. Induced Pluripotent Stem cells (iPSC)
         3.4. Embryonic stem cells (ESC)
         3.5. Neural Stem cells (NSC)
         3.6. Multipotent adult progenitor stem cells

  • 8.   Stem Cell Manufacturing Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Research Applications
         1.1. Life science research
         1.2. Drug discovery and development
        2. Clinical Application
         2.1. Allogenic stem cell therapy
         2.2. Autologous stem cell therapy
        3. Cell & Tissue Banking Applications

  • 9.   Stem Cell Manufacturing Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Pharmaceutical & Biotechnology Companies
        2. Academic institutes, Research laboratories & contract research organizations
        3. Hospitals & surgical centres
        4. Cell & tissue banks
        5. Other End Users

  • 10.   North America Stem Cell Manufacturing Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Stem Cell Manufacturing Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Stem Cell Manufacturing Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Stem Cell Manufacturing Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)

    •   1. Thermo Fisher Scientific
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Merck Millipore
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Lonza Group AG
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Danaher Corporation
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Sartorius AG
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Bio-Rad Laboratories
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Becton, Dickinson and Company
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Stemcell Technologies
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Fujifilm Holdings Corporation
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Miltenyi Biotec
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Terumo BCT Inc.
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. Corning Inc.
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13. Bio-Techne Corporation
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
        14. Takara Bio Group
         14.1. Company Overview
         14.2. Product Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview
        15. Eppendorf AG
         15.1. Company Overview
         15.2. Product Portfolio
         15.3. SWOT Analysis
         15.4. Financial Overview
         15.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client

Ask for Discount
Buy Now
Customize This Report
  • We Offer Special Discounts for start-ups, NGOs, and Educational & Research institutions.

Need Assistance

  • UK : +44 141 628 9353
  • US : +1 347 709 4931

What you get

  • Excel Dataset
  • Market Overview
  • Infographics
  • PowerPoint Presentation
  • PDF Report

What's included

  • Consumer Perception and Procurement
  • Market Data Forecast
  • Competitive Analysis
  • Risks and Opportunity Assessment
  • Market Trends and Dynamics
Partner

Our Clients

image0
image1
image2
image3
image4
image5
image6
image7
image8
image9
image10
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11